First Horizon Advisors, Inc. Veracyte, Inc. Transaction History

First Horizon Advisors, Inc.

$3.58 Billion
Q3 2024

A detailed history of First Horizon Advisors, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 2,596 shares of VCYT stock, worth $112,484. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,596

Previous 2,949 11.97%

Holding current value

$112,484

Previous $63,000 39.68%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$21.0 - $35.25 $7,413 - $12,443	-353 Reduced 11.97%	2,596 $88,000
Q2 2024 Jul 19, 2024	SELL	$18.86 - $23.55 $320 - $400	-17 Reduced 0.57%	2,949 $63,000
Q1 2024 Apr 26, 2024	BUY	$21.0 - $29.1 $777 - $1,076	37 Added 1.26%	2,966 $65,000
Q4 2023 Feb 06, 2024	SELL	$19.72 - $28.68 $828 - $1,204	-42 Reduced 1.41%	2,929 $80,000
Q3 2023 Oct 27, 2023	SELL	$22.33 - $29.92 $18,288 - $24,504	-819 Reduced 21.61%	2,971 $66,000
Q2 2023 Aug 03, 2023	SELL	$20.96 - $26.99 $5,302 - $6,828	-253 Reduced 6.26%	3,790 $96,000
Q1 2023 May 15, 2023	SELL	$20.58 - $27.89 $1,790 - $2,426	-87 Reduced 2.11%	4,043 $90,000
Q4 2022 Feb 10, 2023	BUY	$15.31 - $29.94 $2,051 - $4,011	134 Added 3.35%	4,130 $98,000
Q3 2022 Nov 09, 2022	BUY	$16.58 - $27.9 $4,559 - $7,672	275 Added 7.39%	3,996 $66,000
Q2 2022 Aug 02, 2022	BUY	$15.45 - $29.52 $57,149 - $109,194	3,699 Added 16813.64%	3,721 $74,000
Q1 2022 May 10, 2022	SELL	$21.94 - $42.51 $31,198 - $60,449	-1,422 Reduced 98.48%	22 $1,000
Q4 2021 Feb 09, 2022	BUY	$36.09 - $53.79 $23,494 - $35,017	651 Added 82.09%	1,444 $59,000
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $21,087 - $31,358	592 Added 294.53%	793 $36,000
Q3 2021 Nov 09, 2021	SELL	$35.62 - $52.97 $21,087 - $31,358	-592 Reduced 74.65%	201 $9,000
Q2 2021 Aug 09, 2021	SELL	$32.94 - $56.62 $5,171 - $8,889	-157 Reduced 16.53%	793 $31,000
Q1 2021 May 11, 2021	SELL	$44.47 - $81.38 $4,847 - $8,870	-109 Reduced 10.29%	950 $51,000
Q4 2020 Feb 11, 2021	SELL	$32.49 - $61.88 $4,776 - $9,096	-147 Reduced 12.19%	1,059 $51,000
Q1 2020 May 05, 2020	BUY	$16.13 - $30.17 $3,387 - $6,335	210 Added 21.08%	1,206 $29,000
Q4 2019 Jan 07, 2020	BUY	$20.78 - $29.99 $9,226 - $13,315	444 Added 80.43%	996 $27,000
Q2 2019 Aug 05, 2019	BUY	$22.1 - $28.56 $12,199 - $15,765	552 New	552 $0

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.1B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Account

First Horizon Advisors, Inc. Veracyte, Inc. Transaction History